{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:04:54Z","timestamp":1760043894196},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejim.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T18:15:48Z","timestamp":1394907348000},"page":"e76-e77","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sporadic porphyria cutanea tarda: Treatment with chloroquine decreases hyperglycemia and reduces development of metabolic syndrome"],"prefix":"10.1016","volume":"25","author":[{"given":"Aurora","family":"Gonz\u00e1lez-Estrada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Bonifacio","family":"Gomez-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Gonzalez-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Salvador","family":"Garc\u00eda-Morillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2014.02.009_bb0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/003655100448310","article-title":"Porphyrins, porphyrin metabolism and porphyrias. I. Update","volume":"60","author":"Thunell","year":"2000","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ejim.2014.02.009_bb0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jcp.54.7.500","article-title":"ACP best practice no. 165: front line tests for the investigation of suspected porphyria","volume":"54","author":"Deacon","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejim.2014.02.009_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM196812122792402","article-title":"Porphyria cutanea tarda. A study of the effect of phlebotomy","volume":"279","author":"Epstein","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2014.02.009_bb0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2011.10401.x","article-title":"The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort","volume":"165","author":"Mu\u00f1oz-Santos","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejim.2014.02.009_bb0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF02535017","article-title":"Inhibition of hepatic cholesterol biosynthesis by chloroquine","volume":"16","author":"Beynen","year":"1981","journal-title":"Lipids"},{"key":"10.1016\/j.ejim.2014.02.009_bb0030","first-page":"400","article-title":"Effect of chloroquine on glucose metabolism","volume":"52","author":"Gaafar","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejim.2014.02.009_bb0035","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/art.27703","article-title":"Changes in glycated hemoglobin after initiation of hydroxychloroquine or methotrexate in diabetic patients with rheumatologic diseases","volume":"62","author":"Rekedal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2014.02.009_bb0045","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.090994","article-title":"Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus","volume":"37","author":"Kaprove","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2014.02.009_bb0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2014.02.009_bb0055","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T02:53:30Z","timestamp":1538794410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620514000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0953620514000739"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.02.009","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sporadic porphyria cutanea tarda: Treatment with chloroquine decreases hyperglycemia and reduces development of metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}